Literature DB >> 3973641

Cerebrovascular lesions and livedo reticularis (Sneddon's syndrome)--a progressive cerebrovascular disorder?

E Rumpl, J Neuhofer, A Pallua, J Willeit, G Vogl, G Stampfel, T Platz.   

Abstract

Four cases are described in which livedo reticularis was associated with repeated cerebrovascular accidents, which eventually resulted in severe disability in two cases. Patients with severe disability had a history of many years, whereas two patients with little or moderate residual disability had a follow-up of 3 years each. CT scan revealed multifocal cerebral infarctions and cortical atrophy in all cases. Repeated cerebral angiograms, done in three cases, showed no signs of a vascular disease. There were no parameters that pointed to active immunological or inflammatory disorder. Neither clinical evidence of heart or large vessel disease was found. Observations suggest that a so-far unknown progressive cerebral vessel disease associated with livedo is the cause of a steady increase in multiple small cerebral infarctions. Because of the progressive character of the disease the search for effective therapy is needed.

Entities:  

Mesh:

Year:  1985        PMID: 3973641     DOI: 10.1007/bf00313710

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

Review 1.  Livedo reticularis. Signs in the skin of disturbance of blood viscosity and of blood flow.

Authors:  P W Copeman
Journal:  Br J Dermatol       Date:  1975-11       Impact factor: 9.302

2.  LIVEDO RETICULARIS. A REVIEW.

Authors:  R H CHAMPION
Journal:  Br J Dermatol       Date:  1965-04       Impact factor: 9.302

3.  CEREBRO-VASCULAR LESIONS AND LIVEDO RETICULARIS.

Authors:  I B SNEDDON
Journal:  Br J Dermatol       Date:  1965-04       Impact factor: 9.302

4.  Livedo reticularis.

Authors:  R H CHAMPION; A ROOK
Journal:  Proc R Soc Med       Date:  1960-11

5.  [Anatomoclinical and angiographic study of a case of disseminated thromboangiosis with predominant cerebral manifestations].

Authors:  J Pellat; J Perret; B Pasquier; G Crouzet; G Dubos; R Chateau
Journal:  Rev Neurol (Paris)       Date:  1976-08       Impact factor: 2.607

6.  [Atypical, unilateral livedo pictures].

Authors:  G W Korting; H Lachner
Journal:  Z Haut Geschlechtskr       Date:  1972-01-01

7.  [The so-called livedo racemosa syndrome of the skin with cerebral changes].

Authors:  C Buksowicz; K Niedzielska; J Trzebicki
Journal:  Neurol Neurochir Pol       Date:  1970 Sep-Oct       Impact factor: 1.621

8.  Livedo reticularis and cerebrovascular accidents.

Authors:  S R Quimby; H O Perry
Journal:  J Am Acad Dermatol       Date:  1980-10       Impact factor: 11.527

9.  Livedo reticularis and cerebrovascular lesions (Sneddon's syndrome). Clinical, radiological and pathological features in eight cases.

Authors:  M Rebollo; J F Val; F Garijo; F Quintana; J Berciano
Journal:  Brain       Date:  1983-12       Impact factor: 13.501

10.  Livedo reticularis and neurological lesions.

Authors:  D J Thomas; J D Kirby; K E Britton; D J Galton
Journal:  Br J Dermatol       Date:  1982-06       Impact factor: 9.302

View more
  7 in total

1.  The antiphospholipid syndrome: a syndrome in evolution.

Authors:  R Sinharay
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

2.  Neuropsychological deficits in patients with Sneddon's syndrome.

Authors:  K Weissenborn; N Rückert; C Ehrenheim; S Schellong; C Goetz; D Lubach
Journal:  J Neurol       Date:  1996-04       Impact factor: 4.849

3.  Sneddon's syndrome and phospholipid antibodies.

Authors:  H A Mesa; B Lang; M Schumacher; P Vaith; H H Peter
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

4.  Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus.

Authors:  N J McHugh; J Maymo; R P Skinner; I James; P J Maddison
Journal:  Ann Rheum Dis       Date:  1988-02       Impact factor: 19.103

5.  Sneddon syndrome: cerebral perfusion studies by Tc99m HM-PAO and SPECT.

Authors:  C Canepari; S Cappa; D Perani; M Riva; R Sterzi; F Fazio
Journal:  Ital J Neurol Sci       Date:  1991-02

6.  IGM-containing immune complexes and antiphospholipid antibodies in patients with Sneddon's syndrome.

Authors:  E Schulze-Lohoff; F Krapf; L Bleil; G R Burmester; K Kölble; H G Nüsslein; W Rödl; J R Kalden
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

Review 7.  Sneddon's syndrome: a comprehensive review of the literature.

Authors:  Shengjun Wu; Ziqi Xu; Hui Liang
Journal:  Orphanet J Rare Dis       Date:  2014-12-31       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.